Skip to main content

Iron Triangle Partners LP

SEC CIK
0001779763
Latest filing
Feb 17, 2026

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
22
−5 vs. Q1 2023
Portfolio value
$729.6M
+$36.4M (+5.3%) vs. Q1 2023
Filed
Aug 14, 2023
SEC
Holdings of Iron Triangle Partners LP in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
ICLRIcon PLCCOM350,000$87.6M12.0%+160,000+84.2%AddedHistory
UHSUniversal Health Services IncCL B470,000$74.2M10.2%+470,000NewHistory
ABBVAbbVie Inc.Stock450,000$60.6M8.3%+130,000+40.6%AddedHistory
EXASExact Sciences CorpCOM500,000$47.0M6.4%+500,000NewHistory
BSXBoston Scientific CorpStock850,000$46.0M6.3%+850,000NewHistory
UTHRUnited Therapeutics CorpCOM200,000$44.1M6.1%+200,000NewHistory
ISRGIntuitive Surgical IncCOM NEW120,000$41.0M5.6%00.0%UnchangedHistory
ACHCAcadia Healthcare Company, Inc.COM503,447$40.1M5.5%−9,259−1.8%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM537,906$36.9M5.1%+112,906+26.6%AddedHistory
PACBPacific Biosciences of California, Inc.COM2,400,000$31.9M4.4%+100,000+4.3%AddedHistory
COOCooper Companies, Inc.COM NEW75,000$28.8M3.9%−10,000−11.8%ReducedHistory
SGRYSurgery Partners, Inc.Stock580,973$26.1M3.6%−234,579−28.8%ReducedHistory
ALGNAlign Technology IncCOM65,000$23.0M3.2%+65,000NewHistory
INSPInspire Medical Systems, Inc.COM70,000$22.7M3.1%00.0%UnchangedHistory
GKOSGLAUKOS CorpCOM310,000$22.1M3.0%+310,000NewHistory
TXG10x Genomics, Inc.CL A COM380,000$21.2M2.9%+30,000+8.6%AddedHistory
DXCMDexcom IncCOM150,000$19.3M2.6%−190,000−55.9%ReducedHistory
BKDBrookdale Senior Living Inc.COM4,183,353$17.7M2.4%+1,483,353+54.9%AddedHistory
TMDXTransMedics Group, Inc.COM180,000$15.1M2.1%+180,000NewHistory
SWTXSpringWorks Therapeutics, Inc.COM464,935$12.2M1.7%+152,271+48.7%AddedHistory
MASS908 Devices Inc.COM900,000$6.17M0.8%−150,000−14.3%ReducedHistory
Olink Hldg AB680710100SPONSORED ADS314,795$5.90M0.8%−85,205−21.3%Reduced–

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Iron Triangle Partners LP in Q2 2023
SecurityClassPutsCalls
NBIXNeurocrine Biosciences IncStock$18.5M–

Sold out since Q1 2023 (12)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of Iron Triangle Partners LP sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
SNYSanofiSPONSORED ADR1,179,736$64.2M9.3%History
UNHUnitedHealth Group IncStock80,000$37.8M5.5%History
GILDGilead Sciences, Inc.Stock420,000$34.8M5.0%History
EVHEvolent Health, Inc.CL A1,000,402$32.5M4.7%History
CRLCharles River Laboratories International, Inc.COM130,000$26.2M3.8%History
IDXXIDEXX Laboratories IncCOM50,000$25.0M3.6%History
LEGNLegend Biotech CorpSPONSORED ADS500,000$24.1M3.5%History
SRPTSarepta Therapeutics, Inc.COM160,000$22.1M3.2%History
SDGRSchrodinger, Inc.COM595,697$15.7M2.3%History
CUTRCutera IncCOM600,000$14.2M2.0%History
TSVT2seventy bio, Inc.COMMON STOCK868,939$8.86M1.3%History
STXSStereotaxis, Inc.COM NEW1,832,577$3.74M0.5%History